B72/100

Is Becton Dickinson (BDX) a risky stock?

Sector: Health Care Price: $152.64 Composite: 72/100

As of July 21, 2026, Clavix grades Becton Dickinson (BDX) B for risk, a composite score of 72 out of 100 on an A+ to F scale, which puts BDX in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind BDX's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how BDX scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
63
News sentimentscored, sourced recent coverage
60
Macro exposuresensitivity to rates, dollar, oil
82
Sector resiliencestrength vs the broad market
61
Price stabilitydrawdown and volatility
46

What's moving BDX's risk right now

Company-specific signals Clavix flags behind BDX's current grade, drawn from recent news and filings as of July 21, 2026.

Valuation · supporting the grade

Two asset managers have added to their BDX holdings recently, including a 31.2% increase from Assetmark. Separately, valuation models based on earnings and cash flow suggest the stock is currently undervalued.

Earnings & results · mixed signal

BDX has consistently beaten rating earnings estimates in past quarters, leading some to expect another positive surprise in its upcoming report. A beat would likely give the stock a short-term lift.

What a B grade means

On the Clavix A+ to F scale, BDX's composite of 72 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell BDX or any security. Grades are risk indicators, not predictions of return. Data may be delayed.